Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026)
Precigen (PGEN) posted quarterly Amortizatization of Intangibles of $369000.0 for Q1 2026, down 47.73% year-over-year from $706000.0 in Q1 2025, and down 48.25% quarter-over-quarter from $713000.0 in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Amortizatization of Intangibles for 14 consecutive years, with $369000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 47.73% year-over-year to $369000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 56.71% YoY), while the FY2025 annual figure was $2.2 million, up 149.72% from the prior year.
- Amortizatization of Intangibles eased to $369000.0 in Q1 2026 per PGEN's latest filing, from $713000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $713000.0 in Q4 2025 and bottomed at -$265000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $260823.5 across 5 years, with a median of $318000.0 in 2025.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 364.91% — and 2023, when it jumped 412.12%.
- Precigen's Amortizatization of Intangibles stood at -$165000.0 in 2022, then surged by 412.12% to $515000.0 in 2023, then slumped by 70.68% to $151000.0 in 2024, then surged by 372.19% to $713000.0 in 2025, then slumped by 48.25% to $369000.0 in 2026.
- Business Quant data shows PGEN's Amortizatization of Intangibles at $369000.0 in Q1 2026, $713000.0 in Q4 2025, and $318000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 208,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 208,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 706,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 397,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Sep 30, 2023 | 573,000.00 |
| Jun 30, 2023 | 518,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Dec 31, 2022 | -165,000.00 |
| Sep 30, 2022 | -199,000.00 |
| Jun 30, 2022 | -203,000.00 |
| Mar 31, 2022 | -265,000.00 |
| Dec 31, 2021 | -339,000.00 |
| Sep 30, 2021 | -395,000.00 |